A Hallmark-Based Six-Gene Expression Signature to Assess Colorectal Cancer and Its Recurrence Risk. External Web Site Icon Lu Huiqi et al. Genetic testing and molecular biomarkers 2019 Aug 23(8) 557-564

Specific PHGKB|Cancer|PHGKB

Colorectal Cancer

- Cancer PHGKB -

What's New

Last Posted: Aug 08, 2019

---

• A Hallmark-Based Six-Gene Expression Signature to Assess Colorectal Cancer and Its Recurrence Risk.  
  Lu Huiqi et al. Genetic testing and molecular biomarkers 2019 Aug 23(8) 557-564
• [Hereditary colon cancer in Lynch syndrome/HNPCC syndrome in Germany].  
  Büttner R et al. Der Pathologe 2019 Aug
• Colorectal cancer: pharmacogenetics support for the correct drug prescription.  
  Olivera Gladys et al. Pharmacogenomics 2019 Aug
• Family still matters: Counseling patients with complex family histories of colon and endometrial cancers.  
  Gemmell Amber P et al. Molecular genetics & genomic medicine 2019 Jul e886
• Joint nested frailty models for clustered recurrent and terminal events: An application to colonoscopy screening visits and colorectal cancer risks in Lynch Syndrome families.  
  Choi Yun-Hee et al. Statistical methods in medical research 2019 Jul 962280219863076
• Next Generation Sequencing Reveals Novel Mutations in Mismatch Repair Genes and Other Cancer Predisposition Genes in Asian Patients with Suspected Lynch Syndrome.  
  Ow Samuel G W et al. Clinical colorectal cancer 2019 Jun
• Hereditary ovarian cancers: state of the art.  
  Toss Angela et al. Minerva medica 2019 Aug 110(4) 301-319
• The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer.  
  Taieb Julien et al. Drugs 2019 Jul
• Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.  
  Dominguez-Valentin Mev et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Jul
• Genomic profiling of blood-derived circulating tumor DNA from patients with colorectal cancer: Implications for response and resistance to targeted therapeutics. 
  Choi In Sil et al. Molecular cancer therapeutics 2019 Jul
• Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer With Mutated KRAS.  
  Margalit Ofer et al. Clinical colorectal cancer 2019 Jun
• A comparative study on feature selection for a risk prediction model for colorectal cancer.  
  Cueto-López Nahúm et al. Computer methods and programs in biomedicine 2019 Aug 177219-229
• Establishment and evaluation of prediction model for multiple disease classification based on gut microbial data.  
  Bang Sohyun et al. Scientific reports 2019 Jul 9(1) 10189
• European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects.  
  Keppens Cleo et al. Virchows Archiv : an international journal of pathology 2019 Jul 475(1) 25-37
• Plasma miRNA-based Signatures in CRC Screening Programs.  
  Zanutto Susanna et al. International journal of cancer 2019 Jul